Home > Boards > US Listed > Biotechs > PDL BioPharma Inc. (PDLI)

Do your DD. This one has several patents

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dabonenose Member Profile
 
Followed By 70
Posts 9,790
Boards Moderated 1
Alias Born 10/27/02
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 4:16:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 4:11:56 PM
PDL BioPharma Reports 2019 Third Quarter Financial Results PR Newswire (US) - 11/6/2019 4:05:00 PM
PDL BioPharma to Announce Third Quarter 2019 Financial Results on November 6, 2019 PR Newswire (US) - 10/30/2019 9:00:00 AM
PDL BioPharma Responds to Letter from Engine Capital PR Newswire (US) - 10/24/2019 10:06:00 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/23/2019 8:57:33 AM
Engine Capital Issues Open Letter to Board of PDL BioPharma PR Newswire (US) - 10/23/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/21/2019 7:06:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:01:36 AM
PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference PR Newswire (US) - 9/26/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 5:09:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 6:01:39 AM
PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024 PR Newswire (US) - 9/12/2019 10:20:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2019 6:02:29 AM
PDL BioPharma Announces Favorable Decision in Wellstat Diagnostics Litigation PR Newswire (US) - 9/11/2019 10:44:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/29/2019 4:43:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2019 4:34:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:32:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:24:02 PM
Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 8/5/2019 4:10:00 PM
PDL BioPharma to Announce Second Quarter 2019 Financial Results on August 7, 2019 PR Newswire (US) - 7/31/2019 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/8/2019 5:03:37 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/28/2019 6:01:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 5:25:31 PM
PDL BioPharma Announces Departure of CFO PR Newswire (US) - 6/25/2019 4:05:00 PM
dabonenose   Sunday, 10/25/15 02:19:27 PM
Re: diannedawn post# 186
Post # of 206 
Do your DD. This one has several patents coming off from the Bio's it supports.

FWIW, I took a beating on it.

GLTU however!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist